The SIMICA Consortium

The Instituto de Medicina Molecular João Lobo Antunes (iMM) is a non-profit private research institute affiliated with the University of Lisbon Medical School and located in the campus of the Santa Maria University Hospital. iMM has established itself as a leading national biomedical institute fostering the highest quality basic, clinical and translational biomedical research.

Allcyte (ALLC) is a Austrian biotech company which was founded in 2010 by Dr Krall. The expertise of ALLC, specifically Dr Krall, is in the field of biomarker discovery and development, with early origins working on epigenetic assays. ALLC will assist iMM to produce a companion diagnostic assay for ADCs.

Leiden University Medical Centre (LUMC) is a long-established university medical centre focusing on top clinical and specialized care. This is backed up by top tier research groups including imaging and tumour immunology for which it has world renowned status. It has four large public interest missions: research, education, public health and valorisation of scientific research via technology transfer and industrial partnerships.

Percuros B.V. (PERC), a Dutch biotech-chemistry company, was founded by Alan Chan in 2006 based on blood biomarkers. A KGI spin-off, Zuyder Inc., was subsequently incorporated into Percuros. The Company graduated towards developing biomarker assays for immunotherapy and oncology and to this day it specialises in designing both in vitro and in vivo assays for clients.

The University of Cambridge (UCAM) is one of the most renowned Research/ Higher Education Institutes and is frequently ranked amongst the top 5 in international academic rankings such as ARWU and Shanghai Ranking. It has a long-standing history of academic and scientific excellence backed up with rich culture, learning, research and creativity. The Chemistry Department is consistently ranked in the top three Chemistry Departments worldwide.